Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial

BACKGROUND: Non-alcohol fatty liver disease (NAFLD) is the most common chronic liver disease in the world, with a high incidence and no effective treatment. At present, the targeted therapy of intestinal microbes for NAFLD is highly valued. Lycium barbarum polysaccharide (LBP), as the main active in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lu-Lu, Li, Yu-Xiang, Ma, Jia-Min, Guo, Yi-Qiong, Li, Lin, Gao, Qing-Han, Fan, Yan-Na, Zhang, Meng-Wei, Tao, Xiu-Juan, Yu, Jian-Qiang, Yang, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439032/
https://www.ncbi.nlm.nih.gov/pubmed/34521466
http://dx.doi.org/10.1186/s13063-021-05529-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439032/
https://www.ncbi.nlm.nih.gov/pubmed/34521466
http://dx.doi.org/10.1186/s13063-021-05529-6

Ejemplares similares